Sen. McConnell Hospitalized; WHO Alarms on Salt; Scientists Revive 'Zombie' Virus
(MedPage Today) -- Note that some links may require subscriptions.
Senate Minority Leader Mitch McConnell (R-Ky.) has been hospitalized after a fall, his spokesman said. (Washington Post)
Pfizer's CEO Albert Bourla, PhD, went all in on Mehmet... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - March 9, 2023 Category: Urology & Nephrology Source Type: news
Omecamtiv Mecarbil for Heart Failure Turned Down by FDA
(MedPage Today) -- Heart failure patients won't be getting another drug on the market in the form of omecamtiv mecarbil, now that FDA rejected approval of the cardiac myosin activator.
The agency thus followed the advice of its Cardiovascular... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - March 1, 2023 Category: Urology & Nephrology Source Type: news
Are High Costs of Newer Diabetes Drugs Deterring Eligible Patients?
(MedPage Today) -- Fewer than 10% of eligible U.S. patients with type 2 diabetes used a GLP-1 receptor agonist or SGLT2 inhibitor, according to nationally representative data.
While it was estimated that 22.4 million U.S. adults with diagnosed... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - February 27, 2023 Category: Urology & Nephrology Source Type: news
Calcium Channel Blocker Preserves Some Beta Cell Function in Early T1D
(MedPage Today) -- A calcium channel blocker helped to partially preserve stimulated C-peptide secretion in kids with newly diagnosed type 1 diabetes, although more intensive management did not, according to a randomized clinical trial.
Children... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - February 24, 2023 Category: Urology & Nephrology Source Type: news
Reassuring Findings on Bivalent COVID Booster in Hemodialysis Patients
(MedPage Today) -- Anti-spike IgG concentrations against BA.4/5 significantly increased in patients with end-stage renal disease (ESRD) following a bivalent booster, particularly in those without a prior Omicron infection, a case series from Germany... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - February 16, 2023 Category: Urology & Nephrology Source Type: news
Higher Rates of Staph Infection for Hispanics on Dialysis, CDC Says
(MedPage Today) -- Hispanic dialysis patients have significantly higher rates of Staphylococcus aureus bloodstream infections compared with white dialysis patients, according to a CDC study.
In 2020, rates of S. aureus bloodstream infections in... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - February 7, 2023 Category: Urology & Nephrology Source Type: news
First Oral Treatment for CKD Anemia OK'd for Patients on Dialysis
(MedPage Today) -- The FDA approved the first oral agent for chronic kidney disease (CKD)-related anemia for adults on dialysis, the agency announced late on Wednesday.
Daprodustat (Jesduvroq) is a once-daily tablet specifically indicated for... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - February 2, 2023 Category: Urology & Nephrology Source Type: news
Mom's Cardiovascular Risk After Pre-Eclampsia Emerges Within a Decade
(MedPage Today) -- It did not take long after pregnancy for excess heart attacks and strokes to emerge in women with pre-eclampsia, according to national records from Denmark.
Within 20 years of delivery, the cumulative incidence of acute myocardial... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - January 26, 2023 Category: Urology & Nephrology Source Type: news
Sodium Nitrite in Food, Water Tied to Type 2 Diabetes Risk
(MedPage Today) -- Greater daily exposure to nitrites in food and water may increase the risk for type 2 diabetes, French researchers reported.
Compared with those in the lowest tertile of total nitrite exposure (mean 3.3 mg/day), those exposed... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - January 17, 2023 Category: Urology & Nephrology Source Type: news
Conspiracy Theorists' Cancer Beliefs; HIV Meds and Ethnicity
(MedPage Today) -- TTHealthWatch is a weekly podcast from Texas Tech. In it, Elizabeth Tracey, director of electronic media for Johns Hopkins Medicine in Baltimore, and Rick Lange, MD, president of the Texas Tech University Health Sciences Center... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - January 11, 2023 Category: Urology & Nephrology Source Type: news
Fixing Heart Failure Workforce Issues: Baby Steps Start This Year
(MedPage Today) -- This spring, discussions on how to build a workforce that better meets the needs of the heart failure population will begin in earnest.
The alarming number of unfilled fellowship spots for advanced heart failure and transplant... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - January 5, 2023 Category: Urology & Nephrology Source Type: news
Dementia Accompanying Cardiometabolic Disease: Does It Come Down to Genetics?
(MedPage Today) -- There may be a limit to how much reducing cardiometabolic disease would lower the risk of dementia in older people genetically predisposed to both conditions, a twin study suggested.
Twins over age 60 developed dementia at an... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 29, 2022 Category: Urology & Nephrology Source Type: news
Wegovy OK'd for Teens With Obesity
(MedPage Today) -- The FDA approved injectable semaglutide 2.4 mg (Wegovy) for people with obesity ages 12 and up, maker Novo Nordisk announced.
When paired with diet and exercise, it's now indicated for use in adolescents with an initial BMI... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 29, 2022 Category: Urology & Nephrology Source Type: news
Competitor Poised to Take on Obesity Treatment Giant Wegovy in 2023
In this report, we follow up on what's happened since this approval and what's next.
The FDA green-lit tirzepatide... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 28, 2022 Category: Urology & Nephrology Source Type: news
The Year SGLT2 Inhibitors Became Full-Fledged Heart Failure Drugs
(MedPage Today) -- Earlier this year, empagliflozin (Jardiance) won FDA approval for a broader indication in heart failure across the spectrum of ejection fraction. As part of our review of the year's top stories, we follow up on what has happened... (Source: MedPage Today Nephrology)
Source: MedPage Today Nephrology - December 27, 2022 Category: Urology & Nephrology Source Type: news
